Lv1
30 积分 2024-07-31 加入
Trastuzumab deruxtecan for hormone receptor-positive, HER2-low metastatic breast cancer: Primary results from DESTINY-Breast06, a randomized, phase 3 trial
5个月前
已关闭
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
9个月前
已完结
皖公网安备34019202002308
